ICYMI: She was Diagnosed with Hashimoto’s Thyroiditis but her Doctor Didn’t Know How to Treat It
source: pixabay.com

ICYMI: She was Diagnosed with Hashimoto’s Thyroiditis but her Doctor Didn’t Know How to Treat It

  Susan Mann was seven years old when she was diagnosed as having Hashimoto’s thyroiditis, an autoimmune disease that affects the thyroid. According to a recent article in the online…

Continue Reading ICYMI: She was Diagnosed with Hashimoto’s Thyroiditis but her Doctor Didn’t Know How to Treat It
Two Rare Disease Research Networks Combine to Connect Patients to Research Opportunities
source: pixabay.com

Two Rare Disease Research Networks Combine to Connect Patients to Research Opportunities

As originally reported in Biospace, two research networks dedicated to forming bridges between rare disease research around the world will share their niches to promote discovery for rare diseases. TriNetX…

Continue Reading Two Rare Disease Research Networks Combine to Connect Patients to Research Opportunities
Mitochondrial Disease Patient’s Parents Lose Law Suit Against Four Doctors and Boston Children’s Hospital
source: pixabay.com

Mitochondrial Disease Patient’s Parents Lose Law Suit Against Four Doctors and Boston Children’s Hospital

  The Boston Globe recently interviewed the principals in a case brought by the Pelletier family against the Boston Children’s Hospital. The article gives details about a family’s charge of…

Continue Reading Mitochondrial Disease Patient’s Parents Lose Law Suit Against Four Doctors and Boston Children’s Hospital

Idiopathic Thrombocytopenic Purpura Took the Life of a Teen, but Her Organs Saved the Lives of Others

Abbey Luffman was a 16-year-old from Owego, New York excited about getting her learner's permit. She was also very generous; she didn't even hesitate to check the box for organ…

Continue Reading Idiopathic Thrombocytopenic Purpura Took the Life of a Teen, but Her Organs Saved the Lives of Others
This College Student Turned her Spastic Diplegic Cerebral Palsy into Projects for the Disabled
source: pixabay.com

This College Student Turned her Spastic Diplegic Cerebral Palsy into Projects for the Disabled

  Jennifer Schlegel’s life began earlier than expected with an unanticipated disease. According to an article in The Lantern, Jennifer was born prematurely and diagnosed with spastic diplegic cerebral palsy.…

Continue Reading This College Student Turned her Spastic Diplegic Cerebral Palsy into Projects for the Disabled
2020 Travel Grants from the Jack McGovern Coats’ Disease Foundation: Don’t Miss Out!
source: pixabay.com

2020 Travel Grants from the Jack McGovern Coats’ Disease Foundation: Don’t Miss Out!

The Jack McGovern Coats' Disease Foundation, a nonprofit patient organization committed to supporting critical disease research and raising disease awareness, is offering travel grants for recipients to attend the 2020…

Continue Reading 2020 Travel Grants from the Jack McGovern Coats’ Disease Foundation: Don’t Miss Out!
Bringing Exercise to the ICU Could Improve Outcomes for Pediatric Rare Disease Patients
source: pixabay.com

Bringing Exercise to the ICU Could Improve Outcomes for Pediatric Rare Disease Patients

Sedation Versus Sleep Sleep and sedation are not synonymous terms, despite the fact that they are often used interchangeably in the hospital setting. The biggest difference? Sleep is always beneficial…

Continue Reading Bringing Exercise to the ICU Could Improve Outcomes for Pediatric Rare Disease Patients

First Treatment for Transthyretin Amyloidosis Cardiomyopathy Approved in Europe

As originally reported in Pfizer, the European Commission has just approved the first treatment option ever available to treat transthyretin amyloidosis cardiomyopathy (ATTR-CM). The medication, VYNDAQEL, taken orally once daily,…

Continue Reading First Treatment for Transthyretin Amyloidosis Cardiomyopathy Approved in Europe

The EMA Grants PRIME Designation to Viralym-M To Treat Viral Infections Linked to Stem Cell Transplant

  According to a recent article in The Pharma Letter, the European Medicines Agency (EMA) granted PRIME (PRIority MEdicines) designation to Viralym-M based on positive results from a Phase 2 proof-of-concept…

Continue Reading The EMA Grants PRIME Designation to Viralym-M To Treat Viral Infections Linked to Stem Cell Transplant